tirzepatide eye Weight loss drugs and the worry, this study points to a surprising upside Weight loss drug linked to

Healthcare professionals should maintain awareness of patient-reported symptoms whilst recognising the complex relationship between GLP-1 agonists, their therapeutic effects, and joint symptoms

On the other, we risk medicalising thinness, increasing drug dependency, or diverting access from those most in need

1900 Purified Water, Propanediol, Butyloctyl Salicylate, Dibutyl Adipate, Ethylhexyltriazone, Terephthalylidene Dicamphorsulfonic Acid, Niacinamide, Tromethamine, Polyglyceryl-3 Distearate, Octyldodecanol

Anecdotal reports suggest people continuing treatment may lose an additional 2-5% over the next 24-48 weeks, but rate of loss becomes very slow